Olivier Outteryck

Olivier Outteryck

Auto-generated profile, based on publicly available information

Olivier Outteryck

Service de Neurologie, Hopital Dr Schaffner, Lens

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in The Lancet Neurology
Verified
Journal Article
Closed access
JHJames F Howard
James F Howard
KUKimiaki Utsugisawa
Kimiaki Utsugisawa
MBMichael Benatar
Michael Benatar
HMHiroyuki Murai
Hiroyuki Murai
RBRichard J Barohn
Richard J Barohn
HVHong Vu
Hong Vu

1 October 2017 in The Lancet Neurology
Verified
Journal Article
Closed access
APaxel petzold
axel petzold
LBLaura J Balcer
Laura J Balcer
PCPeter A Calabresi
Peter A Calabresi
FCFiona Costello
Fiona Costello
TFTeresa C Frohman
Teresa C Frohman
EIErn-Eye Imsvisual
Ern-Eye Imsvisual

14 June 2016 in Neurology
Verified
Journal Article
Open access
PDF file
ACAndrés Cruz-Herranz
Andrés Cruz-Herranz
LBLisanne J. Balk
Lisanne J. Balk
TOTimm Oberwahrenbrock
Timm Oberwahrenbrock
SSShiv Saidha
Shiv Saidha
EMElena H. Martinez-Lapiscina
Elena H. Martinez-Lapiscina
FCFiona Costello
Fiona Costello
Objective: To develop consensus recommendations for reporting of quantitative optical coherence tomography (OCT) study results. Methods: A panel of experienced OCT researchers (including 11 neurologists, 2 ophthalmologists, and 2 neuroscientists) discussed requirements for performing and reporting quantitative analyses of retinal morphology and developed a list of initial recommendations based on experience and previous studies. The list of recommendations was subsequently revised during several meetings of the coordinating group. Results: We provide a 9-point checklist encompassing aspects deemed relevant when reporting quantitative OCT studies. The areas covered are study protocol, acquisition device, acquisition settings, scanning protocol, funduscopic imaging, postacquisition data selection, postacquisition data analysis, recommended nomenclature, and statistical analysis. Conclusions: The Advised Protocol for OCT Study Terminology and Elements recommendations include core items to standardize and improve quality of reporting in quantitative OCT studies. The recommendations will make reporting of quantitative OCT studies more consistent and in line with existing standards for reporting research in other biomedical areas. The recommendations originated from expert consensus and thus represent Class IV evidence. They will need to be regularly adjusted according to new insights and practices.

1 May 2016 in The Lancet Neurology
Verified
Journal Article
Closed access
EMElena H Martinez-Lapiscina
Elena H Martinez-Lapiscina
SASam Arnow
Sam Arnow
JWJames A Wilson
James A Wilson
SSShiv Saidha
Shiv Saidha
JPJana Lizrova Preiningerova
Jana Lizrova Preiningerova
PVPablo Villoslada
Pablo Villoslada

16 June 2014 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
SSS Schippling
S Schippling
LBLj Balk
Lj Balk
FCF Costello
F Costello
PAP Albrecht
P Albrecht
LBL Balcer
L Balcer
APaxel petzold
axel petzold
Background: Retinal optical coherence tomography (OCT) permits quantification of retinal layer atrophy relevant to assessment of neurodegeneration in multiple sclerosis (MS). Measurement artefacts may limit the use of OCT to MS research. Objective: An expert task force convened with the aim to provide guidance on the use of validated quality control (QC) criteria for the use of OCT in MS research and clinical trials. Methods: A prospective multi-centre ( n = 13) study. Peripapillary ring scan QC rating of an OCT training set ( n = 50) was followed by a test set ( n = 50). Inter-rater agreement was calculated using kappa statistics. Results were discussed at a round table after the assessment had taken place. Results: The inter-rater QC agreement was substantial (kappa = 0.7). Disagreement was found highest for judging signal strength (kappa = 0.40). Future steps to resolve these issues were discussed. Conclusion: Substantial agreement for QC assessment was achieved with aid of the OSCAR-IB criteria. The task force has developed a website for free online training and QC certification. The criteria may prove useful for future research and trials in MS using OCT as a secondary outcome measure in a multi-centre setting.

2 March 2010 in Neurology
Verified
Journal Article
Closed access
PDF file
NCNicolas Collongues
Nicolas Collongues
RMR. Marignier
R. Marignier
HZH. Zéphir
H. Zéphir
CPC. Papeix
C. Papeix
FBFrederic Blanc
Frederic Blanc
JSJ. de Seze
J. de Seze
Background: There have been few epidemiologic studies on neuromyelitis optica (NMO) and none used the recent 2006 diagnostic criteria. Here we describe the clinical, laboratory, MRI, and disability course of NMO in a French cohort of 125 patients. Methods: We performed an observational, retrospective, multicenter study. Data were collected from September 2007 through August 2008, corresponding to the endpoint of the study. We identified 125 patients fulfilling the 2006 NMO criteria. Selection was made using hospital files and a specific clinical questionnaire for NMO. Results: Mean age at onset was 34.5 years (range 4–66) with a mean disease duration of 10 ± 7.8 years at the endpoint. The patients were mainly (87%) Caucasian, with a female:male ratio of 3:1. In 90% of cases, the association of optic neuritis, longitudinal extensive myelitis, and a Paty-negative initial brain MRI was sufficient to fulfill the supportive criteria. Eighty-eight percent of patients were treated with immunosuppressive therapies. Median delay from onset to Expanded Disability Status Scale (EDSS) score 4 was 7 years; score 6, 10 years; and score 7, 21 years. The first episode of myelitis was immediately followed by an EDSS score ≥4 in 37.3% of cases, and a severe residual visual loss was observed in 22% of patients after the first episode of optic neuritis. Multivariate analysis did not reveal any predictors of a poor evolution other than a high number of MRI brain lesions at diagnosis, which were predictive of a residual visual acuity ≤1/10. Conclusions: Our demographic data provide new data on disability in patients with neuromyelitis optica, most of whom were receiving treatment.